Growth Equity

Fueled by a $100M R&D investment, Chinese beauty giant Yatsen is leading a market shift from price wars to scientific innovation, winning global consumers.

The healthcare REIT is slashing its dividend by 36% to fund a $425M acquisition spree, betting its future on high-end senior housing and a new growth strategy.

An Indigenous-led firm closes its inaugural fund, pioneering a new model of flexible capital to address Canada's chronic Indigenous housing crisis.

Three industry titans launch AlphaDrive, a $100M fund blending VC and private equity to back the next generation of Israeli Cyber-AI startups.

With new backing from Catchment Capital and Stellus, Phoenix-based Vertech is poised to expand its critical role in automating America's industries.

Enabled Talent launches a fellowship with a radical promise: it won't end until participants secure a job, bridging the gap from readiness to results.

The clinical-stage biotech adds seasoned veterans from Eli Lilly and Iovance to accelerate its promising DNA Damage Response pipeline toward commercialization.

The biopharma firm gets a significant non-dilutive cash infusion, bolstering its finances to advance a promising oncology pipeline without equity dilution.

As Rekor Systems preps its Q1 2026 results, investors are watching to see if its AI-driven strategy and cost cuts can sustain momentum and narrow losses.

AI-native firm Norm Law adds veteran tax and fund formation counsel, deepening its tech-driven challenge to the traditional legal services model for investors.

Despite a 19% revenue jump amidst Greece's record tourism year, hotel group The Azur Selection posts a €5.7M loss, triggering a 'going concern' warning.

A new startup unveils an AI server with 128TB of memory, promising to slash costs, lower energy use, and unlock AI models previously thought impossible.

AI Council 2026 reveals the industry's next chapter: European founders are flocking to SF, engineering is being reinvented, and video is set to break everything.

A new AI video solution from V4b.AI promises to solve generative AI's accuracy problem, offering brands a scalable, shoot-free alternative for content.

The firm's oversubscribed fund highlights investor confidence in its strategy of backing founder-owned industrial and services companies.

A Calgary startup's revolutionary wound care gel, already used in hospitals, is now being funded by the government for battlefield trauma applications.

Following a major investment from Gryphon Investors, HRSoft is stacking its board with tech veterans to accelerate growth, product innovation, and M&A.

With a new CEO from finance and media, and $10M in fresh capital, The Block is betting big on becoming the go-to data source for Wall Street's crypto move.

RedHill Biopharma flips a capital deficit to positive equity, driven by savvy partnerships for its drugs Talicia and Bekinda and a promising R&D pipeline.

While many ed-tech firms scale back, 2U secures new capital, betting its future on closing the multi-trillion-dollar AI skills gap with elite partners.